March 2026
M	T	W	T	F	S	S
	1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31

John Amako: Childhood to Adulthood Management Approach for SCD

John Amako/LinkedIn

Jan 13, 2026, 15:22

John Amako: Childhood to Adulthood Management Approach for SCD

John Amako, Branch Manager at United Healthcare International Ltd., shared on LinkedIn:

”Childhood to Adulthood Management approach for Sickle Cell Disease;

Managing Sickle Cell Disease (SCD) involves lifelong care, starting with infancy (antibiotics, hydroxyurea, vaccinations) to prevent infections and crises, progressing through childhood (stroke screening, education for self-advocacy) and adolescence, with a critical transition to adult care focusing on managing complex comorbidities, chronic pain, and self-management, with treatments like hydroxyurea, transfusions, pain management, lifestyle changes, and newer gene therapies offering potential cures, all under a specialized healthcare team.

Childhood Management (Infancy to Adolescence):

Infection Prevention: Daily penicillin until age 5, vaccinations, and prompt attention to fever.
Hydroxyurea: Often started early (around 9 months) to reduce pain crises, acute chest syndrome, and hospitalizations, increasing fetal hemoglobin.
Stroke Prevention: Annual Transcranial Doppler (TCD) ultrasounds from ages 2-16; if abnormal, chronic transfusions or hydroxyurea may be used.
Pain Management: Home management for mild pain (hydration, OTC meds) and prompt care for severe pain.
Education: Teaching children and families about triggers (cold, dehydration) and self-care.

Transition to Adulthood
– Self-Advocacy: Crucial stage where young people learn to manage their own care, transitioning from pediatric to adult hematology teams.
– Increased Complexity: Adults face more organ damage, chronic pain, and psychosocial challenges.
– Healthcare System Gaps: A known risk period for poor outcomes due to fragmented care.
Adult Management and Lifelong Care

Medications:
Hydroxyurea: Still a cornerstone for preventing crises, improving anemia.

L-glutamine (Endari): Reduces pain crises in patients 5+.

Crizanlizumab (Adakveo): Injection to reduce pain crises in those 16+.

Folic Acid: Daily supplementation to support red blood cell production.

Transfusions: Regular chronic transfusions or emergency transfusions for severe complications.

Pain Management: Multimodal approach, including opioids for severe pain, avoiding certain drugs like meperidine (Demerol).

Lifestyle: Stay hydrated, stay warm, avoid extreme temperatures, and manage stress.

Curative Options:

Stem Cell Transplant: Potential cure, but carries risks and requires donors.
Gene Therapies (e.g., Casgevy, Lyfgenia): Newly approved for patients 12+.

Key Principles Across Lifespan

Specialized Team: Care by hematologists, nurses, social workers, and psychologists.
Patient Education: Essential for managing triggers and understanding treatment.
Early Intervention: Prompt treatment for acute issues like chest syndrome, stroke, or severe pain.”

John Amako: Childhood to Adulthood Management Approach for SCD